EUROFINS SCIENTIFIC (ERF.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ERF - FR0014000MR3 - Common Stock
69.28 EUR
+0.42 (+0.61%)
Overall ERF gets a fundamental rating of 5 out of 10. We evaluated ERF against 22 industry peers in the Life Sciences Tools & Services industry. ERF has an average financial health and profitability rating. ERF has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
ERF had positive earnings in the past year.
ERF had a positive operating cash flow in the past year.
ERF had positive earnings in each of the past 5 years.
Each year in the past 5 years ERF had a positive operating cash flow.
1.2 Ratios
ERF has a Return On Assets of 3.54%. This is comparable to the rest of the industry: ERF outperforms 50.00% of its industry peers.
ERF has a Return On Equity (8.09%) which is in line with its industry peers.
ERF has a Return On Invested Capital of 9.79%. This is in the better half of the industry: ERF outperforms 77.27% of its industry peers.
ERF had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 9.06%.
The last Return On Invested Capital (9.79%) for ERF is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ERF has a Profit Margin (5.44%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ERF has grown nicely.
The Operating Margin of ERF (15.59%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ERF has grown nicely.
ERF has a worse Gross Margin (23.29%) than 81.82% of its industry peers.
ERF's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
ERF has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ERF has less shares outstanding than it did 1 year ago.
ERF has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ERF has an improved debt to assets ratio.
2.2 Solvency
ERF has an Altman-Z score of 2.83. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.83, ERF is in line with its industry, outperforming 45.45% of the companies in the same industry.
ERF has a debt to FCF ratio of 5.24. This is a neutral value as ERF would need 5.24 years to pay back of all of its debts.
ERF's Debt to FCF ratio of 5.24 is fine compared to the rest of the industry. ERF outperforms 68.18% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that ERF is somewhat dependend on debt financing.
ERF has a Debt to Equity ratio (0.77) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.24 | ||
| Altman-Z | 2.83 |
ROIC/WACC1.15
WACC8.5%
2.3 Liquidity
A Current Ratio of 1.26 indicates that ERF should not have too much problems paying its short term obligations.
The Current ratio of ERF (1.26) is comparable to the rest of the industry.
ERF has a Quick Ratio of 1.19. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.19, ERF belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ERF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.50%, which is quite good.
Measured over the past years, ERF shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
ERF shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
Based on estimates for the next years, ERF will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.68% on average per year.
Based on estimates for the next years, ERF will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.24, the valuation of ERF can be described as rather expensive.
86.36% of the companies in the same industry are more expensive than ERF, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.19, ERF is valued a bit cheaper.
The Price/Forward Earnings ratio is 17.40, which indicates a rather expensive current valuation of ERF.
Based on the Price/Forward Earnings ratio, ERF is valued cheaper than 86.36% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.92, ERF is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.24 | ||
| Fwd PE | 17.4 |
4.2 Price Multiples
ERF's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ERF is cheaper than 86.36% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ERF indicates a rather cheap valuation: ERF is cheaper than 95.45% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.08 | ||
| EV/EBITDA | 9.4 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ERF may justify a higher PE ratio.
A more expensive valuation may be justified as ERF's earnings are expected to grow with 13.98% in the coming years.
PEG (NY)1.31
PEG (5Y)1.05
EPS Next 2Y13.53%
EPS Next 3Y13.98%
5. Dividend
5.1 Amount
With a yearly dividend of 0.87%, ERF is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.54, ERF pays a better dividend. On top of this ERF pays more dividend than 81.82% of the companies listed in the same industry.
With a Dividend Yield of 0.87, ERF pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
5.2 History
On average, the dividend of ERF grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ERF pays out 54.88% of its income as dividend. This is a bit on the high side, but may be sustainable.
ERF's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.88%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPA:ERF (1/9/2026, 7:00:00 PM)
69.28
+0.42 (+0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.62B
Revenue(TTM)6.89B
Net Income(TTM)375.00M
Analysts68.42
Price Target65.73 (-5.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.87% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.2%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.24 | ||
| Fwd PE | 17.4 | ||
| P/S | 1.83 | ||
| P/FCF | 16.08 | ||
| P/OCF | 9.59 | ||
| P/B | 2.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.4 |
EPS(TTM)3.6
EY5.2%
EPS(NY)3.98
Fwd EY5.75%
FCF(TTM)4.31
FCFY6.22%
OCF(TTM)7.22
OCFY10.42%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.31
PEG (5Y)1.05
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.65% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.11% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.38% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.24 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.98% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.99 | ||
| Cash Conversion | 77.4% | ||
| Profit Quality | 209.23% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.83 |
F-Score7
WACC8.5%
ROIC/WACC1.15
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
EBIT growth 1Y14.06%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.91%
EBIT Next 5Y21.82%
FCF growth 1Y113.26%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.36%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ERF.PA FAQ
What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?
ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.
What is the valuation status for ERF stock?
ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for EUROFINS SCIENTIFIC?
EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for EUROFINS SCIENTIFIC?
The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 14.67% in the next year.
Can you provide the dividend sustainability for ERF stock?
The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 4 / 10 and the dividend payout ratio is 54.88%.